Madagascar vs Sao Tome and Principe: Number of HIV positive pregnant women receiving antiretrovirals
Madagascar
106
in 2011
Sao Tome and Principe
21
in 2011
Madagascar rank
34th
Sao Tome and Principe rank
37th
Number of HIV positive pregnant women receiving antiretrovirals over time
- Madagascar
- Sao Tome and Principe
How they compare
Madagascar currently reports 106 against 21 in Sao Tome and Principe, a difference of 85.
That makes Madagascar's figure about 5.0 times Sao Tome and Principe's.
The two have swapped places 1 time across 5 shared years of data; in 2005 it was Sao Tome and Principe ahead.
Madagascar ranks 34th and Sao Tome and Principe ranks 37th of 38 countries.
Madagascar has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | Madagascar | Sao Tome and Principe | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 14.25 | 13 | 1.25 | Madagascar |
| 2010s | 106 | 21 | 85 | Madagascar |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher number of hiv positive pregnant women receiving antiretrovirals, Madagascar or Sao Tome and Principe?
- Madagascar, at 106 against 21 in Sao Tome and Principe as of 2011.
- What is the difference in number of hiv positive pregnant women receiving antiretrovirals between Madagascar and Sao Tome and Principe?
- 85, with Madagascar ahead.
- How many years of comparable data are there for Madagascar and Sao Tome and Principe?
- 5 years are reported by both, from 2005 to 2011.
- How do Madagascar and Sao Tome and Principe rank globally for number of hiv positive pregnant women receiving antiretrovirals?
- Madagascar ranks 34th and Sao Tome and Principe ranks 37th of 38 countries.
- Where does this data come from?
- http://data.unaids.org/pub/GlobalReport/2008/, published as Number of HIV positive pregnant women receiving antiretrovirals. Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Number of HIV-infected pregnant women who received antiretrovirals during the last 12 months to reduce mother-to-child transmission. The purpose of this indicator is to assess progress in preventing vertical transmission of HIV.